Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells

Journal of Drug Targeting

Volumn 16, Issue 6, 2008, Pages 502-508

  Feng, Meiqing ^a   Cai, Qinsheng ^a   Shi, Xunlong ^a,b   Huang, Hai ^a   Zhou, Pei ^a   Guo, Xin ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Apolipoprotein; HBV; HDL; Liver targeting; Nosiheptide

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LIPOSOME; NOSIHEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG LIVER LEVEL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; APOLIPOPROTEIN A-I; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEASIBILITY STUDIES; HEPATITIS B VIRUS; HEPATOCYTES; LIPOPROTEINS, HDL; LIPOSOMES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; THIAZOLES; TISSUE DISTRIBUTION;

EID: 47649132792     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802200938     Document Type: Article

References (25)

1. Acton, S., Rigotti, A. and Landschulz, KT (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science, 271, pp. 518-520.
2. Allen, TM and Everest, JM (1983) Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J Pharmacol Exp Ther, 226:2, pp. 539-544.
3. Ashwell, G. and Harford, J. (1982) Carbohydrate-specific receptors of the liver. Annu Rev Biochem, 51, pp. 531-554.
4. Benazet, F., Cartier, M., Florent, J., Godard, C., Jung, G., Lunel, J., Mancy, D., Pascal, C., Renaut, J., Tarridec, P., Theilleux, J., Tissier, R., Dubost, M. and Ninet, L. (1980) Nosiheptide, a sulfur-containing peptide antibiotic isolated from Streptomyces actuosus 40037. Experientia, 36:4, pp. 414-616.
5. Bijsterbosch, MK and Van Berkel, TJC (1992) Lactosylated high density lipoprotein: A potential carrier for the site-specific delivery of drugs to parenchymal liver cells. Mol Pharmacol, 41, pp. 404-411.
6. Bijsterbosch, MK, Ziere, GJ and Van Berkel, TJC (1989) Lactosylated low density lipoprotein: A potential carrier for the site-specific delivery of drugs to Kupffer cells. Mol Pharmacol, 36, pp. 484-489.
7. Bijsterbosch, MK, Schouten, D. and Van Berkel, TJC (1994) Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles. Biochemistry, 33, pp. 14073-14080.
8. Bijsterbosch, MK, Van de Bil, H. and Van Berkel, TJC (1996) Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles. Biochem Pharmacol, 52, pp. 113-121.
9. Cai, QS, Huang, H., Feng, MQ and Zhou, P. (2005) Preparation of nosiheptide liposomes and its inhibitory effect on hepatitics B virus in vitro. Acta Pharma Sin, 40:5, pp. 462-465.
10. Feng, MQ, Cai, QS and Song, DX (2004) Expression of human apolipoprotein A-I in Pichia pastoris. Chin J Biotechnol, 20:6, pp. 906-911.
11. Feng, MQ, Cai, QS, Song, DX, Dong, JB and Zhou, P. (2006) High yield and secretion of recombinant human apoAI in P. pastoris. Protein Expr Purif, 46, pp. 337-342.
12. Feng, MQ, Cai, QS, Huang, H. and Zhou, P. (2008) Liver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complex. Eur J Pharm Biopharm, 68, pp. 688-693.
13. Hattori, Y. and Kawakami, S. (2000) Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. J Control Release, 69, pp. 369-377.
14. Horii, S. and Oka, N. (2000) Rapid determination of nosiheptide in meat and egg by liquid chromatograpy with fluorescence detection. J AOAC Int, 83:1, pp. 17-19.
15. Kumar, R., Semaine, W., Johar, M., Tyrrell, DL and Agrawal, B. (2006) Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication. J Med Chem, 49:12, pp. 3693-3700.
16. Leemans, WF, Janssen, HL and de Man, RA (2007) Future prospectives for the management of chronic hepatitis B. World J Gastroenterol, 13:18, pp. 2554-2567.
17. Martinez, LO, Jacquet, S., Esteve, JP, Rolland, C., Cabezon, E., Champagne, E., Pineau, T., Georgeaud, V., Walker, JE, Terce, F., Collet, X., Perret, B. and Barbaras, R. (2003) Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature, 421:6918, pp. 75-79.
18. Pascard, C., Ducruix, A., Lunel, J. and Prange, T. (1977) Highly modified cysteine-containing antibiotics. Chemical structure and configuration of nosiheptide. J Am Chem Soc, 99:19, pp. 6418-6423.
19. Rensen, PCN, De Vrueh, RLA and Kuiper, J. (2001) Recombinant lipoproteins: Ipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev, 47, pp. 251-276.
20. Segrest, JP, Jones, MK, Klon, AE, Sheldahl, CJ, Hellinger, M., De Loof, H. and Harvey, SC (1999) A detail molecular belt model for apolipoportein A-I in discoidal high density lipoprotein. J Biol Chem, 274:45, pp. 31755-31758.
21. Spies, M. (1990) The asialoglycoprotein receptor: A model for endocytic transport receptors. Biochemistry, 29, pp. 10009-10018.
22. Wei, Q., Wu, MP and Chen, PF (1996) Cooperation of HDL receptor and hepatic lipase in the selective uplake of HDL2-CE by rat hepatic simusoidal cells. Acta Biochemical et Biophysica Sinica, 28:6, pp. 661-664.
23. Wu, T., Huang, H. and Zhou, P. (1997) The inhibition of nosiheptide on hepatitis B virus in vitro. Chin J Antibiot, 22:5, pp. 373-376.
24. Zhai, WR, Vajta, G., Acs, G. and Paronetto, F. (1990) A nude mouse model for the in vivo production of hepatitis B virus. Gastroenterology, 98:2, pp. 470-477.
25. Zhou, P., Li, X. and Feng, MQ (1991) Isolation and extraction of nosiheptide. Ind Microbiol, 21:1, pp. 19-22.